MDMA Studies re Medical Benefits

MDMA cleared for Phase III Study in US re PTSD

The FDA cleared MDMA for a Phase III Study under the classification of a potential "Breakthrough Therapy".  However, the study has not yet been funded.  MAPS is currently raising money for the potential study.

Media coverage:  Washington Post, Science Magazine

Press Release:  MAPS Press Release